IgE Allergy Blood Tests Market Trends

  • Report ID: 5551
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

IgE Allergy Blood Tests Market Growth Drivers and Challenges:

Growth Drivers

  • Surge in Pollution Level - According to WHO data, practically all people on the globe (99%) inhale air that is polluted to high levels and exceeds WHO guideline limits; low- and middle-income countries are particularly exposed. Furthermore, 2.4 billion people use polluting open fireplaces or basic stoves powered by coal, kerosene, biomass (wood, animal dung, and agricultural waste), and various other household pollutants, subjecting them to dangerously high levels of air pollution at home. This has further increased the prevalence of allergies. There is a stronger correlation between air pollution and a higher incidence of allergies. A higher concentration of proteins classified as allergenic can be found in pollen in areas with high pollution levels. By getting into physical touch with the pollen particles, DEPs can disrupt the latter. This may result in the release of paucimicronic particles, which then travel by air and have an easier time entering human airways hence further causing allergies.
  • Growing Utilization of mHealth  - Through online marketplaces including Google Play for Android devices and Apple's "App Store" for iOS devices (iPhone, iPad), a vast array of programmes are offered to the general public. Apps have grown more and more popular among patients and healthcare professionals as they are simple to utilize. It has been demonstrated that mHealth apps improve patient-centered outcomes, and physicians frequently recommend apps to their patients. Apps benefit patients of various ages and levels of education due to their diverse feature sets, which include action plans, games, educational content, diaries, and reminders. mHealth apps may remind users to take their prescriptions by sending automated scheduled reminders every day or several times a day. Research has demonstrated that SMS medication reminders for particular chronic illnesses, including asthma, have greatly increased treatment adherence rates across all age groups. Hence, with the growing adoption of mHealth the IgE allergy blood tests market is growing.
  • Rising Prevalence of Food Allergies  - To identify and treat food allergies more effectively, allergen-specific IgE testing is occasionally utilized. Some individuals who are prone to food allergies develop antibodies against specific foods since their immune systems erroneously see them as foreign invaders. For example, people opts for gluten-free food, as they are gluten intolerant. IgE antibodies are the sort of antibodies that are generated. These are distinct from IgG antibodies, which are critical in the defense against viruses and bacteria. For determining if a person is allergic to a food, allergen-specific IgE testing can identify elevated levels of food-specific IgE.

Challenges

  • High Cost Associated with Testing Instruments - Market participants frequently update an array of allergy diagnostic tools, including luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers. The aforementioned instruments are more expensive since they have more features and functionalities (the cost of each instrument varies depending on its accuracy, versatility, and TAT). In addition, extra expenses for operating this technology include overhead (such as electricity, space, and administration), laboratory supervision, maintenance, and insurance. Large hospitals and testing facilities hold a larger IgE allergy blood tests market share because they can afford high-volume systems because of their robust capital budgets. However, because of financial limitations, the majority of small labs, doctor's offices, and independent practitioners are typically unable to purchase huge or extremely large systems.
  • Lack of Awareness Among the General Public 
  • Lack of Professionals to Handle the Instruments 

Base Year

2025

Forecast Period

2026-2035

CAGR

6.5%

Base Year Market Size (2025)

USD 34.19 billion

Forecast Year Market Size (2035)

USD 64.18 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of IgE allergy blood tests is evaluated at USD 36.19 billion.

The global IgE allergy blood tests market size was worth over USD 34.19 billion in 2025 and is poised to grow at a CAGR of around 6.5%, reaching USD 64.18 billion revenue by 2035.

North America igE allergy blood tests market will hold more than 30% share by 2035, driven by growing adoption of health insurance and advanced testing instruments.

Key players in the market include Thermo Fisher Scientific Inc., Siemens Healthineers AG, Hycor Biomedical, LLC, Euroimmun AG (PerkinElmer), Quest Diagnostics Incorporated, LabCorp (Laboratory Corporation of America Holdings), Bio-Rad Laboratories, Inc., GenWay Biotech, Inc., Alere Inc. (Abbott), Stallergenes Greer.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos